GGrantIndex
← Leaderboards

Sergio A Villalta

University Of California Los Angeles

$4,161,131
Attributed
$4,388,394
Total exposure
7
Grants
6
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $850.7K · FY200625
$1M$750K$500K$250K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$4,388,394 · 7

By mechanism

R01$2,474,312 · 1
R21$1,382,086 · 3
T32$340,894 · 1
F32$114,616 · 1
F31$76,486 · 1

Top collaborators

Most similar at University Of California Los Angeles

Same institution · by research overlap

Others in their field

Top investigators on “Muscle

Research focus

MuscleImmune SystemMacrophageDisease ProgressionMolecularInflammationCellsCell CommunicationInjuryMediatingInflammatoryComplexMuscular DystrophiesInsightNatural RegenerationChronicInflammatory ResponseImmuneRegulatory T-LymphocytePathogenesisReportingInterleukin-10Duchenne Muscular DystrophyAblation

Grant awards (23)

MAXIMUS: MAXimizing Training in MUScle Research$237,956
T32 · FY2025 · AR
Novel macrophage and regulatory T cell interactions that promote the pathogenesis of Duchenne muscular dystrophy$398,837
R01 · FY2024 · NS · contact PI
High-dimensional mass imaging of muscle for the mechanistic study of T cells in inclusion body myositis$268,030
R21 · FY2024 · AR · contact PI
MAXIMUS: MAXimizing Training in MUScle Research$102,938
T32 · FY2024 · AR
Novel macrophage and regulatory T cell interactions that promote the pathogenesis of Duchenne muscular dystrophy$18,620
R01 · FY2024 · NS · contact PI
Novel macrophage and regulatory T cell interactions that promote the pathogenesis of Duchenne muscular dystrophy$430,215
R01 · FY2023 · NS · contact PI
High-dimensional mass imaging of muscle for the mechanistic study of T cells in inclusion body myositis$276,320
R21 · FY2023 · AR · contact PI
Novel macrophage and regulatory T cell interactions that promote the pathogenesis of Duchenne muscular dystrophy$81,256
R01 · FY2023 · NS · contact PI
Novel macrophage and regulatory T cell interactions that promote the pathogenesis of Duchenne muscular dystrophy$426,485
R01 · FY2022 · NS · contact PI
Novel macrophage and regulatory T cell interactions that promote the pathogenesis of Duchenne muscular dystrophy$81,256
R01 · FY2022 · NS · contact PI
Novel macrophage and regulatory T cell interactions that promote the pathogenesis of Duchenne muscular dystrophy$62,636
R01 · FY2022 · NS · contact PI
Novel macrophage and regulatory T cell interactions that promote the pathogenesis of Duchenne muscular dystrophy$422,861
R01 · FY2021 · NS · contact PI
Novel macrophage and regulatory T cell interactions that promote the pathogenesis of Duchenne muscular dystrophy$114,502
R01 · FY2021 · NS · contact PI
Novel macrophage and regulatory T cell interactions that promote the pathogenesis of Duchenne muscular dystrophy$18,298
R01 · FY2021 · NS · contact PI
Tolerization of dystrophin and adeno-associated virus immunity$431,375
R21 · FY2020 · NS · contact PI
Novel macrophage and regulatory T cell interactions that promote the pathogenesis of Duchenne muscular dystrophy$419,346
R01 · FY2020 · NS · contact PI
Group 2 innate lymphoid cells in tissue regeneration$183,868
R21 · FY2018 · AI · contact PI
Group 2 innate lymphoid cells in tissue regeneration$222,493
R21 · FY2017 · AI · contact PI
Regulatory T cells in Duchenne muscular dystrophy$58,946
F32 · FY2014 · AR · contact PI
Regulatory T cells in Duchenne muscular dystrophy$55,670
F32 · FY2013 · AR · contact PI
Immune and muscle cell interactions that modulate dystrophinopathy$17,310
F31 · FY2008 · AR · contact PI
Immune and muscle cell interactions that modulate dystrophinopathy$29,588
F31 · FY2007 · AR · contact PI
Immune and muscle cell interactions that modulate dystrophinopathy$29,588
F31 · FY2006 · AR · contact PI